Countries World
NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...
April 21, 2026 | News
First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...
April 21, 2026 | News
New slurried chromatography resins eliminate resin hydration step to help accelerate downstream purification of oligonucleotides and peptides DuPont annou...
April 20, 2026 | News
First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams ...
April 20, 2026 | News
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...
April 17, 2026 | News
Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, announced that ...
April 15, 2026 | News
VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed ...
April 15, 2026 | News
Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) ...
April 14, 2026 | News
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Corp...
April 14, 2026 | News
Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, announc...
April 13, 2026 | News
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...
April 13, 2026 | News
Parnell announced the acquisition of Noble Pharma LLC, a U.S.-based pharmaceutical manufacturer, according to the Securities Purchase Agreement dated Novem...
April 10, 2026 | News
Lumonus, the company behind Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, announced a collaboration wit...
April 09, 2026 | News
Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful R...
April 08, 2026 | News
Most Read
Bio Jobs
News
Editor Picks